166 related articles for article (PubMed ID: 34060350)
1. Transcriptome Analysis and the Prognostic Role of NUDC in Diffuse and Intestinal Gastric Cancer.
Jeong SH; Park M; Park SY; Park J; Kim TH; Lee YJ; Jung EJ; Ju YT; Jeong CY; Kim JY; Ko GH; Kim M; Nam KT; Goldenring JR
Technol Cancer Res Treat; 2021; 20():15330338211019501. PubMed ID: 34060350
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer.
Lim JY; Yoon SO; Seol SY; Hong SW; Kim JW; Choi SH; Cho JY
World J Gastroenterol; 2012 Aug; 18(30):4037-43. PubMed ID: 22912555
[TBL] [Abstract][Full Text] [Related]
3. Signet ring cell component, not the Lauren subtype, predicts poor survival: an analysis of 198 cases of gastric cancer.
de Aguiar VG; Segatelli V; Macedo ALV; Goldenberg A; Gansl RC; Maluf FC; Usón Junior PLS
Future Oncol; 2019 Feb; 15(4):401-408. PubMed ID: 30620220
[TBL] [Abstract][Full Text] [Related]
4. Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.
Luo D; Huang H; Lu ML; Zhao GF; Chang J; Zheng MY; Wang Y
Pathol Oncol Res; 2012 Apr; 18(2):491-7. PubMed ID: 22109561
[TBL] [Abstract][Full Text] [Related]
5. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics and Prognostic Analysis of Patients With Signet Ring Cell Gastric Carcinoma.
Yu JM; Zhan ZW; Zhen JX; Wang XJ; Chen Y; Lin J; Chen L; Chen LZ; Huang YF; Guo ZQ
Technol Cancer Res Treat; 2020; 19():1533033820983812. PubMed ID: 33371800
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of signet ring cell carcinoma of the stomach.
Kim JP; Kim SC; Yang HK
Surg Oncol; 1994 Aug; 3(4):221-7. PubMed ID: 7834113
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma].
Xiong ZF; Xiao H; Tan YS
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171
[TBL] [Abstract][Full Text] [Related]
9. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
[TBL] [Abstract][Full Text] [Related]
10. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
12. Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia.
Chon HJ; Hyung WJ; Kim C; Park S; Kim JH; Park CH; Ahn JB; Kim H; Chung HC; Rha SY; Noh SH; Jeung HC
Ann Surg; 2017 May; 265(5):946-953. PubMed ID: 27232252
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer.
Senapati S; Chaturvedi P; Sharma P; Venkatraman G; Meza JL; El-Rifai W; Roy HK; Batra SK
Br J Cancer; 2008 Sep; 99(6):949-56. PubMed ID: 18781152
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype.
Seo HM; Chang YS; Joo SH; Kim YW; Park YK; Hong SW; Lee SH
J Surg Oncol; 2009 Mar; 99(3):143-7. PubMed ID: 19117018
[TBL] [Abstract][Full Text] [Related]
15. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
16. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma.
İlhan Ö; Han Ü; Önal B; Çelık SY
Turk J Gastroenterol; 2010 Dec; 21(4):345-52. PubMed ID: 21331986
[TBL] [Abstract][Full Text] [Related]
18. Gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognostic significance based on histopathological subtypes.
Kwon CH; Kim YK; Lee S; Kim A; Park HJ; Choi Y; Won YJ; Park DY; Lauwers GY
Histopathology; 2018 Mar; 72(4):556-568. PubMed ID: 28873240
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and clinicopathological significance of long noncoding RNA CTD-2510F5.4 in gastric cancer.
Wang Z; Qin B
Gastric Cancer; 2019 Jul; 22(4):692-704. PubMed ID: 30560474
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin E is a marker of gastric differentiation and signet-ring cell carcinoma of stomach: a novel suggestion on gastric tumorigenesis.
Konno-Shimizu M; Yamamichi N; Inada K; Kageyama-Yahara N; Shiogama K; Takahashi Y; Asada-Hirayama I; Yamamichi-Nishina M; Nakayama C; Ono S; Kodashima S; Fujishiro M; Tsutsumi Y; Ichinose M; Koike K
PLoS One; 2013; 8(2):e56766. PubMed ID: 23451082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
